Soland Daniel B
ACADIA Pharmaceuticals Inc. · Director
Soland Daniel B is listed in filings as Director at ACADIA Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 2, 2025, including 3 public disclosures. Recent filings connect the profile to ACADIA Pharmaceuticals Inc. (ACAD). The current snapshot covers public activity from Jun 2, 2025. Reported amounts are shown as $307.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||